615558-47-9Relevant academic research and scientific papers
Nhatrangin A: Total Syntheses of the Proposed Structure and Six of Its Diastereoisomers
Dias, Luiz C.,Polo, Ellen C.
, p. 4072 - 4112 (2017/04/28)
A total synthesis of the proposed structure of nhatrangin A is described. This strategy relies on two aldol reactions to install the chiral centers at C3/C4 and C3′/C4′, a lithium-mediated coupling between an advanced intermediate alkyne and a Weinreb amide to complete the C1-C13 alkyl scaffold, and a Yamaguchi esterification to set the side chain. Discrepancies in the spectroscopic data between synthetic and natural nhatrangins led us to synthesize six more diastereoisomers of the proposed structure of nhatrangin A.
Novel triarylimidazoles
-
Page/Page column 7, (2010/02/11)
Compounds of the general formula (I) are presented and are valuable therapeutics for the treatment of cancer and cancer related diseases.
PHENYL-[4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IGF-IR INHIBITORS
-
Page/Page column 37, (2008/06/13)
The present invention relates to a compound of formula (I) and derivatives thereof. Furthermore, the invention relates to the use of such compounds as medicaments. In addition, the invention relates to the use of such compounds for manufacturing a medicament useful for treating proliferative diseases.
2-(2,6-dichlorophenyl)-diarylimidazoles
-
Page/Page column 11; 12, (2010/11/29)
The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.
